Latest News and Press Releases
Want to stay updated on the latest news?
-
BRISBANE, Calif., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Oppenheimer 25th Annual Healthcare...
-
BRISBANE, Calif., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Jefferies 2014 Global London Healthcare...
-
-- UCD Product Portfolio Generates $26.2 Million in Net Sales During the Quarter -- -- Company Delivers Fifth Consecutive Quarter of Adjusted Net Income -- -- Company to Host Conference Call...
-
BRISBANE, Calif., Oct. 31, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report third quarter 2014 financial results after market close on Thursday,...
-
BRISBANE, Calif. and RAMAT GAN, Israel, Oct. 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) ("Hyperion") and Clal Biotechnology Industries Ltd. (TASE:CBI) ("CBI") today...
-
BRISBANE, Calif., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Leerink Rare Disease Roundtable on...
-
BRISBANE, Calif., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the Company will hold an Analyst Day on Tuesday, September 30, 2014, from 9:00 a.m....
-
Company Discovers Serious Misconduct by Andromeda Biotech Ltd. Company to Host Conference Call Today at 9:00 a.m. ET (6:00 a.m. PT) BRISBANE, Calif., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Hyperion...
-
BRISBANE, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced the appointment of Theodore "Ted" Schroeder to its board of directors effective August 11,...
-
UCD Product Portfolio Generates $37.1 Million in Net Sales During the Quarter --$31.6 million of RAVICTI® recognized in the quarter including $11.7 million of previously deferred...